Professional Summary
Professional Overview
Chang King-Ming is a seasoned biotechnology leader and visionary entrepreneur. As the Founder and CEO of ESCO Bioengineering, he oversees the strategic direction and operations of this innovative bioengineering company. Additionally, he serves as the Chief Technology Officer (CTO) of ESCO ASTER, driving the development of cutting-edge technology solutions for the biotech industry.
Experience Summary
Current Role
As the Founder and CEO of ESCO Bioengineering, Chang King-Ming is responsible for setting the company's strategic vision, driving innovation, and leading a talented team of professionals. Under his leadership, ESCO Bioengineering has become a renowned provider of high-quality bioengineering solutions, serving clients across Taiwan and the broader Asia-Pacific region. As the CTO of ESCO ASTER, he oversees the development and deployment of advanced technological platforms that empower the biotech industry to operate more efficiently and effectively.
Career Progression
Prior to his current roles, Chang King-Ming founded CESCO Bioengineering Co., Ltd. in 2002, where he served as the Founder and Chief Research Officer (CRO). In this capacity, he spearheaded the company's research and development efforts, contributing to the advancement of bioengineering technologies. Before embarking on his entrepreneurial journey, Chang held the position of Director at the Industrial Technology Research Institutes, where he leveraged his deep technical expertise to drive innovation and foster collaboration within the industry.
Academic Background
Chang King-Ming holds a Bachelor's degree in Bioengineering from a prestigious university in Taiwan, where he graduated with distinction. His academic background and specialization in bioengineering have been instrumental in shaping his career trajectory and enabling him to lead innovative initiatives in the biotechnology sector.
Areas of Expertise
Chang King-Ming's areas of expertise include:
- Bioengineering technology development
- Biopharmaceutical manufacturing process optimization
- Automation and robotics for laboratory applications
- Artificial intelligence and machine learning for biotech data analysis
- Strategic leadership and organizational development
Professional Impact
Under Chang King-Ming's visionary leadership, ESCO Bioengineering has emerged as a leading provider of innovative bioengineering solutions, serving clients across a wide range of industries. The company's flagship products and technologies have been instrumental in improving efficiency, productivity, and quality control in various biotech and pharmaceutical applications. Through his contributions as the CTO of ESCO ASTER, Chang has also been instrumental in driving the development of cutting-edge technological platforms that enable the biotech industry to operate more efficiently and effectively.
Conclusion
With his deep technical expertise, entrepreneurial acumen, and strategic vision, Chang King-Ming has established himself as a prominent figure in the biotechnology industry. As he continues to lead ESCO Bioengineering and ESCO ASTER, he is poised to drive further innovation and growth, positioning his organizations at the forefront of the rapidly evolving biotech landscape.
